Cross-Protective Immunity against Multiple Influenza Virus Subtypes by a Novel Modified Vaccinia Ankara (MVA) Vectored Vaccine in Mice

Development of an influenza vaccine that provides cross-protective immunity remains a challenge. Candidate vaccines based on a recombinant modified vaccinia Ankara (MVA) viral vector expressing antigens from influenza (MVA/Flu) viruses were constructed. A vaccine candidate, designated MVA/HA(1)/C13L...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Vaccine
Asıl Yazarlar: Brewoo, Joseph N., Powell, Tim D., Jones, Jeremy C., Gundlach, Nancy A., Young, Ginger R., Das, Subash C., Partidos, Charalambos D., Stinchcomb, Dan T., Osorio, Jorge E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224110/
https://ncbi.nlm.nih.gov/pubmed/23376279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.01.038
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller